Screener
Immuneering Corporation IMRX Q1 2026 earnings
Reported May 15, 2026 · Before market open
EPS-$0.21Beat by $0.09
EPS estimate-$0.30
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.29
Versus estimates
Diluted EPS
FAQ
- When did Immuneering Corporation report Q1 2026 earnings?
- Immuneering Corporation (IMRX) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Immuneering Corporation's Q1 2026 revenue and EPS?
- Immuneering Corporation reported eps of $-0.21 for Q1 2026.
- Did Immuneering Corporation beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.30 by $0.09.
- How did Immuneering Corporation's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 50.0% from $-0.42.
- Where can I find Immuneering Corporation's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001790340-26-000055) and the 10-Q periodic report (0001790340-26-000057) directly on SEC EDGAR. The filing index links above go to sec.gov.
